Silver Book

Silver Book Fact

“Coronary heart disease spending has increased more than 40% over the past 15 years, and, as a whole, the health improvements have been well worth the costs. Over the entire population, spending on coronary heart disease and its major risk factors has resulted in a life-expectancy increase of 0.62 years, at an incremental cost of $43,600 per year of life gained. Life expectancy following a myocardial infraction has increased by nearly a year, at an incremental cost of $24,800 per life-year gained.”

Rosen A, Cutler D, Norton D, Hu H. The Value of Coronary Heart Disease Care for the Elderly: 1987-2002. Health Affairs. 2007; 26(1): 111-123. https://www.healthaffairs.org/doi/full/10.1377/hlthaff.26.1.111

Reference

Title
The Value of Coronary Heart Disease Care for the Elderly: 1987-2002
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Rosen A, Cutler D, Norton D, Hu H
Volume & Issue
Volume 26, Issue 1
Pages
111-123
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • In the 1980s, approximately 400,000 major infarctions were occurring each year in the U.S. and 40% of patients were dying within the first year. 1-year mortality is now 4-8%.  
  • The volume of mitral valve surgical procedures increased approximately 8.3% from 2010 to 2013.
     
  • In the absence of antihypertensive drug therapy, there would have been an estimated 572,000 more hospital discharges for stroke in 2002, and 261,000 more discharges for myocardial infarction. The…  
  • Treatment for hypertension using antihypertensive therapy has generated a benefit-to-cost ratio of at least 6:1.  
  • There are currently 312 medicines in development for heart disease and stroke.